{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T21:51:19Z","timestamp":1777067479662,"version":"3.51.4"},"reference-count":100,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Increasing evidence shows the nasal epithelium to be the initial site of SARS-CoV-2 infection, and that early and effective immune responses in the upper respiratory tract (URT) limit and eliminate the infection in the URT, thereby preventing infection of the lower respiratory tract and the development of severe COVID-19. SARS-CoV-2 interferes with innate immunity signaling and evolves mutants that can reduce antibody-mediated immunity in the URT. Recent genetic and immunological advances in understanding innate immunity to SARS-CoV-2 in the URT, and the ability of prior infections as well as currently available injectable and potential intranasal COVID-19 vaccines to generate anamnestic adaptive immunity in the URT, are reviewed. It is suggested that the more detailed investigation of URT immune responses to all types of COVID-19 vaccines, and the development of safe and effective COVID-19 vaccines for intranasal administration, are important needs.<\/jats:p>","DOI":"10.3390\/v14050933","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T08:21:25Z","timestamp":1651652485000},"page":"933","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Innate and Adaptive Immune Responses in the Upper Respiratory Tract and the Infectivity of SARS-CoV-2"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0246-7053","authenticated-orcid":false,"given":"Ranjan","family":"Ramasamy","sequence":"first","affiliation":[{"name":"ID-FISH Technology, 556 Gibraltar Drive, Milpitas, CA 95035, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"ref_1","unstructured":"(2022, April 20). Johns Hopkins University of Medicine, Coronavirus Resource Centre. Available online: https:\/\/coronavirus.jhu.edu\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"12910","DOI":"10.1074\/jbc.REV120.013930","article-title":"The molecular virology of coronaviruses","volume":"295","author":"Hartenian","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Papa, G., Mallery, D.L., Albecka, A., Welch, L.G., Cattin-Ortol\u00e1, J., Luptak, J., Paul, D., McMahon, H.T., Goodfellow, I.G., and Carter, A. (2021). Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009246"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/15459624.2020.1784427","article-title":"Relative contributions of transmission routes for COVID-19 among healthcare personnel providing patient care","volume":"17","author":"Jones","year":"2020","journal-title":"J. Occup. Environ. Hyg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ijid.2020.09.025","article-title":"Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients","volume":"100","author":"Lednicky","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"12732","DOI":"10.1038\/s41598-020-69286-3","article-title":"Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care","volume":"10","author":"Santarpia","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"Corman","year":"2020","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e148517","DOI":"10.1172\/JCI148517","article-title":"Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19","volume":"131","author":"Ahn","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc2001737","article-title":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","volume":"382","author":"Zou","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e0013021","DOI":"10.1128\/JVI.00130-21","article-title":"Human nasal and lung tissues infected ex vivo with SARS-CoV-2 provide insights into differential tissue-specific and virus-specific innate immune responses in the upper and lower respiratory tract","volume":"95","author":"Alfi","year":"2021","journal-title":"J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"112890","DOI":"10.1016\/j.envres.2022.112890","article-title":"A multi-tissue study of immune gene expression profiling highlights the key role of the nasal epithelium in COVID-19 severity","volume":"210","year":"2022","journal-title":"Environ. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41590-021-01091-0","article-title":"Innate immunity: The first line of defense against SARS-CoV-2","volume":"23","author":"Diamond","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ramasamy, R. (2020). Nasal conditioning of inspired air, innate immunity in the respiratory tract and SARS-CoV-2 infectivity. Open Sci. Forum.","DOI":"10.31219\/osf.io\/4j95b"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ramasamy, R. (2021). Perspective of the relationship between the susceptibility to initial SARS-CoV-2 infectivity and optimal nasal conditioning of inhaled air. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22157919"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Laporte, M., Raeymaekers, V., Van Berwaer, R., Vandeput, J., Marchand-Casas, I., Thibaut, H.J., Van Looveren, D., Martens, K., Hoffmann, M., and Maes, P. (2021). The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways. PLoS Pathog., 17.","DOI":"10.1371\/journal.ppat.1009500"},{"key":"ref_18","first-page":"1","article-title":"Immunity to human influenza A\u2014An overview","volume":"4","author":"Ramasamy","year":"2010","journal-title":"Brunei Darussalam J. Health"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bj.2018.08.004","article-title":"The role of respiratory epithelium in host defence against influenza virus infection","volume":"41","author":"Denney","year":"2018","journal-title":"Biomed. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1038\/s41467-021-23018-x","article-title":"Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients","volume":"12","author":"Nguyen","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Mifsud, E.J., Kuba, M., and Barr, I.G. (2021). Innate immune responses to influenza virus infections in the upper respiratory tract. Viruses, 13.","DOI":"10.3390\/v13102090"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41467-020-14626-0","article-title":"Influenza A viruses are transmitted via the air from the nasal respiratory epithelium of ferrets","volume":"11","author":"Richard","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.4187\/respcare.07332","article-title":"The oral-lung axis: The impact of oral health on lung health","volume":"65","author":"Gaeckle","year":"2020","journal-title":"Respir. Care"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: Immunopathology and its implications for therapy","volume":"20","author":"Cao","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41467-021-20991-1","article-title":"Assessing the influence of climate on wintertime SARS-CoV-2 outbreaks","volume":"12","author":"Baker","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nri.2016.117","article-title":"Early local immune defences in the respiratory tract","volume":"17","author":"Iwasaki","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1038\/s41467-021-27318-0","article-title":"Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2","volume":"12","author":"Hatton","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"m3249","DOI":"10.1136\/bmj.m3249","article-title":"Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: Prospective multi-centre observational cohort study","volume":"370","author":"Swann","year":"2020","journal-title":"BMJ"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jamapediatrics.2020.1467","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: A systematic review","volume":"174","author":"Castagnoli","year":"2020","journal-title":"JAMA Pediatr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"15927","DOI":"10.1038\/s41598-021-95532-3","article-title":"Immune cell residency in the nasal mucosa may partially explain respiratory disease severity across the age range","volume":"11","author":"Winkley","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41587-021-01037-9","article-title":"Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children","volume":"40","author":"Loske","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e148694","DOI":"10.1172\/jci.insight.148694","article-title":"Natural mucosal barriers and COVID-19 in children","volume":"6","author":"Pierce","year":"2021","journal-title":"JCI Insight"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-021-04345-x","article-title":"Local and systemic responses to SARS-CoV-2 infection in children and adults","volume":"602","author":"Yoshida","year":"2022","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e20210583","DOI":"10.1084\/jem.20210583","article-title":"Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics","volume":"218","author":"Cheemarla","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1016\/j.cell.2021.07.023","article-title":"Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19","volume":"184","author":"Ziegler","year":"2021","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e20211211","DOI":"10.1084\/jem.20211211","article-title":"Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs","volume":"218","author":"Lopez","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"618685","DOI":"10.3389\/fimmu.2020.618685","article-title":"Distinct features and functions of systemic and mucosal humoral immunity among SARS-CoV-2 convalescent individuals","volume":"11","author":"Butler","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"eabd2223","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2249.2003.02311.x","article-title":"Nasal-associated lymphoid tissue (NALT): Frequency and localization in young children","volume":"134","author":"Debertin","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41586-021-03610-3","article-title":"SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis","volume":"594","author":"Finkel","year":"2021","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e00065-21","DOI":"10.1128\/mBio.00065-21","article-title":"SARS-CoV-2 ORF6 disrupts bidirectional nucleocytoplasmic transport through interactions with Rae1 and Nup98","volume":"12","author":"Addetia","year":"2021","journal-title":"Mbio"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1038\/s41467-021-26910-8","article-title":"SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis","volume":"12","author":"Yoo","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"101522","DOI":"10.1016\/j.smim.2021.101522","article-title":"Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities","volume":"55","author":"Galani","year":"2021","journal-title":"Semin. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41586-021-03732-8","article-title":"Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques","volume":"596","author":"Yu","year":"2021","journal-title":"Nature"},{"key":"ref_46","first-page":"1","article-title":"The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron","volume":"10","author":"Zhang","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41586-022-04460-3","article-title":"T cell responses to SARS-CoV-2 spike cross-recognize Omicron","volume":"603","author":"Keeton","year":"2022","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-022-04465-y","article-title":"Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron","volume":"603","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2022.01.015","article-title":"SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron","volume":"185","author":"Tarke","year":"2022","journal-title":"Cell"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41591-022-01700-x","article-title":"Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant","volume":"28","author":"Gao","year":"2022","journal-title":"Nat. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"eabo2202","DOI":"10.1126\/sciimmunol.abo2202","article-title":"Divergent SARS-CoV-2 Omicron-reactive T and B cell responses in COVID-19 vaccine recipients","volume":"7","author":"GeurtsvanKessel","year":"2022","journal-title":"Sci. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S0140-6736(22)00327-0","article-title":"Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: A prospective observational study from the ZOE COVID Study","volume":"399","author":"Menni","year":"2022","journal-title":"Lancet"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"n3151","DOI":"10.1136\/bmj.n3151","article-title":"COVID-19: Hospital admission 50-70% less likely with omicron than delta, but transmission a major concern","volume":"375","author":"Mahase","year":"2021","journal-title":"BMJ"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijid.2022.02.051","article-title":"Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections\u2014A survival analysis","volume":"118","author":"Hussey","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"100930","DOI":"10.1016\/j.mgene.2021.100930","article-title":"A variant in TMPRSS2 is associated with decreased disease severity in COVID-19","volume":"29","author":"Ravikanth","year":"2021","journal-title":"Meta Gene"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41588-021-00955-3","article-title":"Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus","volume":"53","author":"Downes","year":"2021","journal-title":"Nat. Genet."},{"key":"ref_57","unstructured":"(2021, December 14). The Protein Atlas. Available online: https:\/\/www.proteinatlas.org\/ENSG00000163818-LZTFL1\/tissue."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"COVID-19 Host Genetics Initiative (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472\u2013477.","DOI":"10.1038\/s41586-021-03767-x"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41588-021-00854-7","article-title":"Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity","volume":"53","author":"Shelton","year":"2021","journal-title":"Nat. Genet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/vox.13076","article-title":"ABO blood group and COVID-19: A review on behalf of the ISBT COVID-19 Working Group","volume":"116","author":"Goel","year":"2021","journal-title":"Vox Sang."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","article-title":"Genetic mechanisms of critical illness in COVID-19","volume":"591","author":"Clohisey","year":"2021","journal-title":"Nature"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41588-022-01042-x","article-title":"Expanded COVID-19 phenotype definitions reveal distinct patterns of genetic association and protective effects","volume":"54","author":"Roberts","year":"2022","journal-title":"Nat. Genet."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/s41577-021-00631-x","article-title":"The immunology of asymptomatic SARS-CoV-2 infection: What are the key questions?","volume":"21","author":"Boyton","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41586-021-04186-8","article-title":"Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2","volume":"601","author":"Swadling","year":"2022","journal-title":"Nature"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Wragg, K.M., Lee, W.S., Koutsakos, M., Tan, H.X., Amarasena, T., Reynaldi, A., Gare, G., Konstandopoulos, P., Field, K.R., and Esterbauer, R. (2022). Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory. Nat. Immunol.","DOI":"10.1038\/s41590-022-01175-5"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"eaam6970","DOI":"10.1126\/sciimmunol.aam6970","article-title":"Resident memory CD8+ T cells in the upper respiratory tract prevent pulmonary influenza virus infection","volume":"2","author":"Pizzolla","year":"2017","journal-title":"Sci. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41590-021-01095-w","article-title":"Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19","volume":"23","author":"Roukens","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaci.2020.10.040","article-title":"Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19","volume":"147","author":"Cervia","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/s41467-021-25949-x","article-title":"SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms","volume":"12","author":"Gillard","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41586-021-03647-4","article-title":"SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans","volume":"595","author":"Turner","year":"2021","journal-title":"Nature"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41586-021-03696-9","article-title":"Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41577-021-00578-z","article-title":"Immunological mechanisms of vaccine-induced protection against COVID-19 in humans","volume":"21","author":"Sadarangani","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1038\/s41591-021-01540-1","article-title":"Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection","volume":"27","author":"Feng","year":"2021","journal-title":"Nat. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.abm3425","article-title":"Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial","volume":"375","author":"Gilbert","year":"2022","journal-title":"Science"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"116","DOI":"10.20411\/pai.v6i1.441","article-title":"Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva","volume":"6","author":"Ketas","year":"2021","journal-title":"Pathog. Immun."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"eabj0299","DOI":"10.1126\/science.abj0299","article-title":"Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates","volume":"373","author":"Corbett","year":"2021","journal-title":"Science"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"744887","DOI":"10.3389\/fimmu.2021.744887","article-title":"The mucosal and serological immune responses to the novel coronavirus (SARS-CoV-2) vaccines","volume":"12","author":"Chan","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41541-021-00315-6","article-title":"ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets","volume":"6","author":"Marsh","year":"2021","journal-title":"NPJ Vaccines"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"eabf1555","DOI":"10.1126\/scitranslmed.abf1555","article-title":"Enhanced SARS-CoV-2 neutralization by dimeric IgA","volume":"13","author":"Wang","year":"2021","journal-title":"Sci. Transl Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"eabj7211","DOI":"10.1126\/scitranslmed.abj7211","article-title":"AZD1222\/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein-specific TH1 response with a diverse TCR repertoire","volume":"13","author":"Swanson","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"eabk0894","DOI":"10.1126\/sciimmunol.abk0894","article-title":"Identification of resident memory CD8+ T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue","volume":"6","author":"Niessl","year":"2021","journal-title":"Sci. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1750-2659.2008.00056.x","article-title":"Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza","volume":"2","author":"Ambrose","year":"2008","journal-title":"Influ. Other Respir. Viruses"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"King, R.G., Silva-Sanchez, A., Peel, J.N., Botta, D., Dickson, A.M., Pinto, A.K., Meza-Perez, S., Allie, S.R., Schultz, M.D., and Liu, M. (2021). Single-dose intranasal administration of AdCOVID elicits systemic and mucosal immunity against SARS-CoV-2 and fully protects mice from lethal challenge. Vaccines, 9.","DOI":"10.3390\/vaccines9080881"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): A single-blind, randomised, controlled, phase 2\/3 trial","volume":"396","author":"Ramasamy","year":"2020","journal-title":"Lancet"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-020-01194-5","article-title":"T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1\/2 clinical trial","volume":"27","author":"Ewer","year":"2021","journal-title":"Nat. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"eabh0755","DOI":"10.1126\/scitranslmed.abh0755","article-title":"Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models","volume":"13","author":"Purushotham","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13578-021-00723-0","article-title":"Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2","volume":"11","author":"Cao","year":"2021","journal-title":"Cell Biosci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e148494","DOI":"10.1172\/jci.insight.148494","article-title":"Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques","volume":"6","author":"Sui","year":"2021","journal-title":"JCI Insight"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1016\/j.vaccine.2006.02.040","article-title":"Immunogenicity of a malaria parasite antigen displayed by Lactococcus lactis in oral immunizations","volume":"24","author":"Ramasamy","year":"2006","journal-title":"Vaccine"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1016\/j.vaccine.2007.01.070","article-title":"Mucosal immunization of mice with malaria protein on lactic acid bacterial cell walls","volume":"25","author":"Moorthy","year":"2007","journal-title":"Vaccine"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.vaccine.2009.06.011","article-title":"Age-dependent systemic antibody responses and immunization-associated changes in mice orally and nasally immunized with Lactococcus lactis expressing a malaria parasite protein","volume":"27","author":"Moorthy","year":"2009","journal-title":"Vaccine"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ijbiomac.2021.08.232","article-title":"Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2","volume":"190","author":"Li","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1016\/j.drudis.2021.07.021","article-title":"Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management","volume":"26","author":"Chavda","year":"2021","journal-title":"Drug Discov. Today"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"120686","DOI":"10.1016\/j.ijpharm.2021.120686","article-title":"Nasal vaccination against SARS-CoV-2: Synergistic or alternative to intramuscular vaccines?","volume":"603","author":"Tiboni","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_98","unstructured":"Paul, W.E. (2003). Fundamental Immunology, Lippincott Williams & Wilkins. [6th ed.]."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41590-021-01114-w","article-title":"Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules","volume":"23","author":"Stravalaci","year":"2022","journal-title":"Nat. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e20200872","DOI":"10.1084\/jem.20200872","article-title":"Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients","volume":"217","author":"Jouan","year":"2020","journal-title":"J. Exp. Med."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/5\/933\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:03:53Z","timestamp":1760137433000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/5\/933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":100,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["v14050933"],"URL":"https:\/\/doi.org\/10.3390\/v14050933","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]}}}